Jeil Pharmaceutical Co Ltd (271980) — Working Capital to Net Assets Ratio
Jeil Pharmaceutical Co Ltd (271980) has a Working Capital to Net Assets ratio of 32.3% as of June 2026. Working capital of ₩81.81 Billion (current assets of ₩330.25 Billion minus current liabilities of ₩248.44 Billion) is measured against net assets of ₩253.26 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Jeil Pharmaceutical Co Ltd (271980) defensive interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Jeil Pharmaceutical Co Ltd Working Capital to Net Assets (2017–2025)
This chart shows how Jeil Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 32.3%, reflecting working capital of ₩81.81 Billion against net assets of ₩253.26 Billion KRW. For the complete balance sheet picture, see 271980 total asset value.
Annual Working Capital to Net Assets for Jeil Pharmaceutical Co Ltd (2017–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Jeil Pharmaceutical Co Ltd from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check how resilient are Jeil Pharmaceutical Co Ltd's assets to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 27.6% | ₩69.17 Billion | ₩251.03 Billion | ₩311.62 Billion | ₩242.45 Billion | ▲ +4.1 pp |
| 2024 | 23.4% | ₩51.35 Billion | ₩219.32 Billion | ₩343.04 Billion | ₩291.69 Billion | ▲ +24.1 pp |
| 2023 | -0.7% | ₩-1.12 Billion | ₩157.03 Billion | ₩317.05 Billion | ₩318.17 Billion | ▼ -15.5 pp |
| 2022 | 14.8% | ₩22.98 Billion | ₩155.60 Billion | ₩291.64 Billion | ₩268.66 Billion | ▼ -22.7 pp |
| 2021 | 37.5% | ₩62.73 Billion | ₩167.35 Billion | ₩284.67 Billion | ₩221.94 Billion | ▲ +3.0 pp |
| 2020 | 34.5% | ₩59.45 Billion | ₩172.48 Billion | ₩277.51 Billion | ₩218.06 Billion | ▲ +1.8 pp |
| 2019 | 32.7% | ₩55.61 Billion | ₩170.04 Billion | ₩264.13 Billion | ₩208.52 Billion | ▼ -9.9 pp |
| 2018 | 42.6% | ₩78.80 Billion | ₩184.93 Billion | ₩273.36 Billion | ₩194.56 Billion | ▼ -9.2 pp |
| 2017 | 51.8% | ₩92.15 Billion | ₩177.99 Billion | ₩298.60 Billion | ₩206.46 Billion | — |